Dihydropyrimidinones containing boronic acids

Author: Blacquiere Johanna M   Sicora Oana   Vogels Christopher M   Čuperlović-Culf Miroslava   Decken Andreas   Ouellette Rodney J   Westcott Stephen A  

Publisher: NRC Research Press

ISSN: 1480-3291

Source: Canadian Journal of Chemistry, Vol.83, Iss.12, 2005-12, pp. : 2052-2059

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The addition of formylphenylboronic acid derivatives to urea and ethyl acetoacetate proceeds in the absence of an additional Lewis acid catalyst to give the corresponding dihydropyrimidinones (Biginelli products) in good yields. Novel boron-containing dihydropyrimidinones have been investigated for their ability to act as anticancer agents against the breast cancer cell line MCF7.Key words: anticancer, Biginelli compounds, boronic acids, breast cancer, dihydropyrimidinones.L'addition de dérivés de l'acide formylphénylboronique sur l'urée et l'acétoacétate d'éthyle se produit, même en l'absence d'un catalyseur acide de Lewis additionnel, pour conduire à la formation de dihydropyrimidinones (produits de Biginelli), avec de bons rendements. On a examiné les propriétés antitumorales des nouvelles dihydropyrimidinones contenant du bore en faisant appel à des cellules de cancer du sein de la souche MCF7.Mots clés : antitumorale, composés de Biginelli, acides boroniques, cancer du sein, dihydropyrimidinones.[Traduit par la Rédaction]

Related content